The prevalence of self-monitoring of blood glucose and costs of glucometer strips in a nationwide cohort

Diabetes Technology and Therapeutics

Volumn 12, Issue 9, 2010, Pages 701-705

  Kjome, Reidun L S ^a   Granas, Anne G ^a   Nerhus, Kari ^a   Roraas, Thomas H ^a   Sandberg, Sverre ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DIABETIC PATIENT; DRUG MARKETING; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; NORWAY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF MONITORING; TEST STRIP;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PREVALENCE; REAGENT STRIPS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77955673012     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0056     Document Type: Article

References (22)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
2. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-713. Erratum in: BMJ 1999;318:29.
3. The International Diabetes Federation's Clinical Guidelines Task Force. Self-monitoring. In: Global Guideline for Type 2 Diabetes. Brussels: IDF Communications, 2005. www.idf.org (accessed January 28, 2010).
4. Claudi T, ed.: Nasjonale faglige retningslinjer: Diabetes- Forebygging, diagnostikk og behandling [National Professional Guidelines for Prevention, Diagnostics and Treatment of Diabetes]. Oslo: Helsedirektoratet, 2009.
5. American Diabetes Association: Standards of medical care in diabetes-2009. Diabetes Care 2009;32(Suppl 1):S13-S61.
6. Hansen MV, Pedersen-Bjergaard U, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV, Pramming S, Thorsteinsson B: Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009;85:183-188.
7. Sanyal C, Graham SD, Cooke C, Sketris I, Frail DM, Flowerdew G: The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada. BMC Health Serv Res 2008;8:111.
8. Centers for Disease Control and Prevention (CDC): Selfmonitoring of blood glucose among adults with diabetes- United States, 1997-2006. MMWR Morb Mortal Wkly Rep 2007;56:1133-1137.
9. Clinical Diagnostics Growth Partnership Service: Strategic Analysis Service. Global In Vitro Diagnostics Market Outlook. Publication number F352-65. Palo Alto, CA: Frost & Sullivan, 2005.
10. Bergenstal RM, Gavin JR III: The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005;118(Suppl 9A): 1S-6S.
11. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R: Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technol Assess 2000;4(12):i-iv, 1-93.
12. Tunis SL, Minshall ME: Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care 2008;14:131-140.
13. Neeser K, Erny-Albrecht K, Weber C: Cost-effectiveness of self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin. Diabetes Care 2006;29:480-481.
14. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A: Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335:132.
15. McAndrew L, Schneider SH, Burns E, Leventhal H: Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ 2007;33: 991-1011.
16. Davis WA, Bruce DG, Davis TM: Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510-515.
17. The Norwegian Health Economics Administration (HELFO): About HELFO. www.helfo.no/omhelfo/Sider/about-helfo .aspx (accessed February 15, 2010).
18. Norwegian Institute of Public Health: The Norwegian Prescriptions Database. www.reseptregisteret.no/Prevalens .aspx (accessed February 15, 2010).
19. Hanko B, Kazmer M, Kumli P, Hragyel Z, Samu A, Vincze Z, Zelko R: Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes. Pharm World Sci 2007;29:58-66.
20. Fraud squad to probe pharmacy scam allegations. www .independent.ie/ health/latest-news/fraud-squad-to-probepharmacy- scam-allegations-1841470.html (published July 26, 2009; accessed February 25, 2010).
21. Elizabeth pharmacy employee charged with insurance fraud. www.nj.com/suburbannews/index.ssf/2009/10/elizabeth- pharmacy-employee-ch.html (published October 19, 2009; accessed February 25, 2010).
22. Kristensen GB, Monsen G, Skeie S, Sandberg S: Standardized evaluation of nine instruments for self-monitoring of blood glucose. Diabetes Technol Ther 2008;10:467-477.